These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567 [TBL] [Abstract][Full Text] [Related]
4. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis. Laforêt P; Richard P; Said MA; Romero NB; Lacene E; Leroy JP; Baussan C; Hogrel JY; Lavergne T; Wahbi K; Hainque B; Duboc D Neuromuscul Disord; 2006 Mar; 16(3):178-82. PubMed ID: 16487706 [TBL] [Abstract][Full Text] [Related]
5. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279 [TBL] [Abstract][Full Text] [Related]
6. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. Akman HO; Sampayo JN; Ross FA; Scott JW; Wilson G; Benson L; Bruno C; Shanske S; Hardie DG; Dimauro S Pediatr Res; 2007 Oct; 62(4):499-504. PubMed ID: 17667862 [TBL] [Abstract][Full Text] [Related]
7. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095 [TBL] [Abstract][Full Text] [Related]
8. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830 [TBL] [Abstract][Full Text] [Related]
9. Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage. Kim M; Hunter RW; Garcia-Menendez L; Gong G; Yang YY; Kolwicz SC; Xu J; Sakamoto K; Wang W; Tian R Circ Res; 2014 Mar; 114(6):966-75. PubMed ID: 24503893 [TBL] [Abstract][Full Text] [Related]
11. A familial form of conduction defect related to a mutation in the PRKAG2 gene. Charron P; Genest M; Richard P; Komajda M; Pochmalicki G Europace; 2007 Aug; 9(8):597-600. PubMed ID: 17483151 [TBL] [Abstract][Full Text] [Related]
12. A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia. Banerjee SK; Ramani R; Saba S; Rager J; Tian R; Mathier MA; Ahmad F Biochem Biophys Res Commun; 2007 Aug; 360(2):381-7. PubMed ID: 17597581 [TBL] [Abstract][Full Text] [Related]
13. Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen. Folmes KD; Chan AY; Koonen DP; Pulinilkunnil TC; Baczkó I; Hunter BE; Thorn S; Allard MF; Roberts R; Gollob MH; Light PE; Dyck JR Circ Cardiovasc Genet; 2009 Oct; 2(5):457-66. PubMed ID: 20031621 [TBL] [Abstract][Full Text] [Related]
14. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome. Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108 [TBL] [Abstract][Full Text] [Related]
15. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. Daniel T; Carling D J Biol Chem; 2002 Dec; 277(52):51017-24. PubMed ID: 12397075 [TBL] [Abstract][Full Text] [Related]
16. Familial Wolff-Parkinson-White Syndrome: a disease of glycogen storage or ion channel dysfunction? Light PE J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S158-S161. PubMed ID: 16686673 [TBL] [Abstract][Full Text] [Related]
17. A contemporary approach to hypertrophic cardiomyopathy. Ho CY; Seidman CE Circulation; 2006 Jun; 113(24):e858-62. PubMed ID: 16785342 [No Abstract] [Full Text] [Related]
18. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation. Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659 [TBL] [Abstract][Full Text] [Related]